LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $299,600 | -16.9% | 5,000 | 0.0% | 0.05% | -11.5% |
| Q2 2023 | $360,500 | -2.0% | 5,000 | 0.0% | 0.05% | -8.8% |
| Q1 2023 | $367,800 | +10.1% | 5,000 | 0.0% | 0.06% | +5.6% |
| Q4 2022 | $334,000 | -22.5% | 5,000 | 0.0% | 0.05% | -27.0% |
| Q3 2022 | $431,000 | -3.4% | 5,000 | 0.0% | 0.07% | +1.4% |
| Q2 2022 | $446,000 | -20.6% | 5,000 | 0.0% | 0.07% | -3.9% |
| Q1 2022 | $562,000 | -27.2% | 5,000 | 0.0% | 0.08% | -21.6% |
| Q4 2021 | $772,000 | +10.8% | 5,000 | 0.0% | 0.10% | +2.1% |
| Q3 2021 | $697,000 | +6.2% | 5,000 | 0.0% | 0.10% | +9.2% |
| Q2 2021 | $656,000 | -13.9% | 5,000 | 0.0% | 0.09% | -19.4% |
| Q1 2021 | $762,000 | +53.3% | 5,000 | 0.0% | 0.11% | +40.3% |
| Q4 2020 | $497,000 | +4.2% | 5,000 | 0.0% | 0.08% | -10.5% |
| Q3 2020 | $477,000 | -14.7% | 5,000 | 0.0% | 0.09% | -18.1% |
| Q2 2020 | $559,000 | +53.6% | 5,000 | 0.0% | 0.10% | +26.5% |
| Q1 2020 | $364,000 | -30.1% | 5,000 | 0.0% | 0.08% | -5.7% |
| Q4 2019 | $521,000 | +4.6% | 5,000 | 0.0% | 0.09% | -3.3% |
| Q3 2019 | $498,000 | -12.8% | 5,000 | 0.0% | 0.09% | -10.8% |
| Q2 2019 | $571,000 | -9.2% | 5,000 | 0.0% | 0.10% | -10.5% |
| Q1 2019 | $629,000 | +54.5% | 5,000 | +66.7% | 0.11% | +34.1% |
| Q4 2018 | $407,000 | -17.6% | 3,000 | +66.7% | 0.08% | +1.2% |
| Q3 2018 | $494,000 | +19.3% | 1,800 | -10.0% | 0.08% | +13.5% |
| Q2 2018 | $414,000 | -58.2% | 2,000 | -66.7% | 0.07% | -58.2% |
| Q1 2018 | $991,000 | +20.6% | 6,000 | 0.0% | 0.18% | +24.6% |
| Q4 2017 | $822,000 | +50.8% | 6,000 | +50.0% | 0.14% | +43.4% |
| Q3 2017 | $545,000 | -32.6% | 4,000 | -40.0% | 0.10% | -35.3% |
| Q2 2017 | $809,000 | +14.6% | 6,666 | 0.0% | 0.15% | +14.2% |
| Q1 2017 | $706,000 | +4.3% | 6,666 | 0.0% | 0.13% | -0.7% |
| Q4 2016 | $677,000 | -0.4% | 6,666 | 0.0% | 0.14% | -4.3% |
| Q3 2016 | $680,000 | -14.5% | 6,666 | 0.0% | 0.14% | -16.6% |
| Q2 2016 | $795,000 | +1.7% | 6,666 | 0.0% | 0.17% | +1.8% |
| Q1 2016 | $782,000 | +8.2% | 6,666 | 0.0% | 0.17% | +12.2% |
| Q4 2015 | $723,000 | +26.6% | 6,666 | 0.0% | 0.15% | +19.4% |
| Q3 2015 | $571,000 | -15.2% | 6,666 | 0.0% | 0.12% | -5.3% |
| Q2 2015 | $673,000 | +30.9% | 6,666 | 0.0% | 0.13% | +32.3% |
| Q1 2015 | $514,000 | +44.8% | 6,666 | 0.0% | 0.10% | +43.5% |
| Q4 2014 | $355,000 | +13.4% | 6,666 | 0.0% | 0.07% | +7.8% |
| Q3 2014 | $313,000 | -24.6% | 6,666 | 0.0% | 0.06% | -22.0% |
| Q2 2014 | $415,000 | -7.4% | 6,666 | 0.0% | 0.08% | -10.9% |
| Q1 2014 | $448,000 | – | 6,666 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |